PD12-01 TREATMENT OF RECURRENT LOW-GRADE INTERMEDIATE-RISK NON-MUSCLE INVASIVE BLADDER CANCER WITH UGN-102: ONGOING RESULTS FROM A SINGLE-ARM, OPEN-LABEL, PHASE 3 TRIAL (ENVISION)

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

The Journal of Urology

Topics

Internal Medicine

Surgery

Medicine

Internal Medicine

Surgery

Open Label

Urothelial Cancer

Show all topics

DOI

10.1097/01.ju.0001109848.08748.9e.01